Election Outcome Heightens Budget Uncertainty, NOC Drops but WAIT Thesis Intact

What happened

Northrop Grumman shares fell on November 4, 2026, after midterm election results gave Democrats control of both the Senate and House, raising the likelihood of defense budget constraints. The Pentagon was already bracing for its record $1.5 trillion budget request to be trimmed to $1.1 trillion, and a Democratic Congress increases the odds of such cuts becoming formalized. This development directly amplifies the appropriations risk already flagged in NOC's 10-K, where an extended continuing resolution or shutdown could disrupt new program starts and payment timing, pressuring near-term cash conversion. NOC's Q1 2026 results already showed a $157 million net unfavorable B-21 LRIP EAC adjustment and a $1.0 billion loss accrual, making the stock highly sensitive to any deterioration in funding visibility. Despite the selloff, shares remain above the $485 attractive entry level identified in our June report, and the WAIT rating stands as we await evidence of B-21 execution improvement and budget clarity.

Implication

Investors should treat the election outcome as a confirmation of existing appropriations risk rather than a new bear thesis, as the FY26 budget process was already unresolved. The stock's reaction reflects a reduction in the 'conflict premium' that had driven defense names higher, but NOC's $95.6 billion backlog and 84% U.S. government revenue still provide long-cycle demand visibility. Near-term, the key catalysts remain unchanged: the next 10-Q must show a net favorable B-21 LRIP EAC adjustment or a meaningful decline in the $1.0 billion loss accrual, and budget enactment must avoid adverse impacts on new starts. Given the higher probability of budget cuts, the bear case probability (25%) may need upward revision, but the base case (55%) still assumes learning-curve progress and cash conversion normalization, supporting a fair value around $575. With the stock at $577 post-drop, it sits near base-case value, offering little margin of safety; disciplined investors should wait for a pullback toward $485 or clear evidence of B-21 de-risking before adding.

Thesis delta

The WAIT rating is affirmed, but the political shift tilts risk toward the bear case. The probability of sustained adverse appropriations/funding delays increases, which could further pressure cash flow and sentiment in the next 3-6 months. No change to valuation triggers: attractive entry remains $485, trim above $610; monitor upcoming 10-Q for B-21 EAC trends.